Status:

COMPLETED

LEVITRA® Specific Drug Use Investigation. To Investigate the Safety Profile in Combination Use With Alpha-blockers

Lead Sponsor:

Bayer

Conditions:

Erectile Dysfunction

Eligibility:

MALE

18+ years

Brief Summary

Main object is to investigate the safety profile of Levitra in combination use with alpha-blockers in patients with erectile dysfunction used in clinical practice after launch. In the initial combina...

Eligibility Criteria

Inclusion

  • Patients \>/= 18 years
  • Enrollment within 7 days after initiation of combination use of Levitra and alpha-blockers

Exclusion

    Key Trial Info

    Start Date :

    October 1 2007

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    March 1 2010

    Estimated Enrollment :

    491 Patients enrolled

    Trial Details

    Trial ID

    NCT01207947

    Start Date

    October 1 2007

    End Date

    March 1 2010

    Last Update

    January 21 2015

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Many Locations, Japan

    LEVITRA® Specific Drug Use Investigation. To Investigate the Safety Profile in Combination Use With Alpha-blockers | DecenTrialz